Peregrine Capital Management LLC Black Diamond Therapeutics, Inc. Transaction History

Peregrine Capital Management LLC

  • $3.31 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021
SELL
$12.19 - $28.17 $2.25 Million - $5.19 Million
-184,253 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$22.23 - $34.75 $570,377 - $891,615
-25,658 Reduced 12.22%
184,253 $4.47 Million
Q4 2020

Jan 19, 2021
BUY
$29.47 - $35.0 $542,572 - $644,385
18,411 Added 9.61%
209,911 $6.73 Million
Q3 2020

Oct 20, 2020
BUY
$26.17 - $43.07 $5.01 Million - $8.25 Million
191,500 New
191,500 $5.79 Million

Others Institutions Holding BDTX

# of Institutions
100
Shares Held
47.3M
Call Options Held
108K
Put Options Held
24.8K
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $154M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email